UK markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
10,622.00-22.00 (-0.21%)
At close: 06:30PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 323.27%
S&P500 52-week change 3-9.85%
52-week high 311,886.00
52-week low 38,214.00
50-day moving average 311,260.96
200-day moving average 310,676.20

Share statistics

Avg vol (3-month) 32M
Avg vol (10-day) 32.16M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 10.22%
% held by institutions 148.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.22
Forward annual dividend yield 42.09%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 30.03%
5-year average dividend yield 42.88
Payout ratio 4221.36%
Dividend date 3N/A
Ex-dividend date 411 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 4.52%
Operating margin (ttm)22.55%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)5.45%

Income statement

Revenue (ttm)45.16B
Revenue per share (ttm)29.16
Quarterly revenue growth (yoy)11.30%
Gross profit (ttm)27.61B
EBITDA 13.65B
Net income avi to common (ttm)2.04B
Diluted EPS (ttm)1.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.52B
Total cash per share (mrq)2.92
Total debt (mrq)31.27B
Total debt/equity (mrq)88.97
Current ratio (mrq)0.81
Book value per share (mrq)22.70

Cash flow statement

Operating cash flow (ttm)8.83B
Levered free cash flow (ttm)10.39B